Company
Nanollose Limited
Headquarters: Nedlands, WA, Australia
Market Cap
A$3.7 Million
AUD as of Jan. 1, 2024
US$2.5 Million
Nanollose Limited Categories
Australia Healthcare BiotechnologyAustralia Healthcare Australia Biotechnology
Top Competitors by Market Capitalization
Industry: Biotechnology
| Company | Market Cap (USD) |
|---|---|
| Novo Nordisk | $461.52 B |
| Vertex Pharmaceuticals Incorporated | $107.23 B |
| Regeneron Pharmaceuticals, Inc. | $100.01 B |
| CSL Limited | $94.74 B |
| Marinomed Biotech AG | $73.23 B |
Sector:
| Company | Market Cap (USD) |
|---|---|
| Lilly | $586.39 B |
| UnitedHealth Group | $504.47 B |
| Novo Nordisk | $461.52 B |
| Johnson & Johnson | $387.50 B |
| Merck | $296.51 B |
Detailed Description
Nanollose Limited, a biotechnology company, engages in the research and development, and promotion of the microbial nanocellulose technology in Australia. It offers Nullarbor Fibre, a plant-free viscose-rayon fibre; Nullarbor Garment, a wearable garment using Nullarbor tree-free rayon; and Jelli Grow, an alternative seed germination and plant growing material. The company's products are used in textiles, nonwoven fabric, and other industries. Nanollose Limited was incorporated in 2014 and is based in Nedlands, Australia.
Top 1-year algo backtest: +269.94%
$10,000 in May 2023 would now be $36,994 by following this algorithm daily at market close.
Boost your stocks returns with Disfold AI... Now!
Try Disfold AI for FREE
Stocks & Indices
Nanollose Limited has the following listings and related stock indices.
Stock: ASX: NC6 wb_incandescent